TrialDrug safety2023

Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study.

David R Cornblath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.